UBS Lowers C3.ai Price Target to $9

Analyst: Radi Sultan 1 min read Reproduced verbatim
Rating
Neutral
Target
$9
from $14.50 (−38%)
Outcome
Reached
on February 26, 2026
UBS and C3.ai logos

What the analyst said

UBS analyst Radi Sultan lowered the price target on C3.ai (NYSE: AI) to $9.00 (from $14.50) while maintaining a Neutral rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

AI trades at $11.69. The 3 analysts who set a target in the last 3 months range from $7 to $12.50, with a median of $12. This $9 target is 25% below the median.

Since the note AI has moved +13% (from $10.31). 12-month window: day 254 of 365, closes on February 26, 2027.

Track record

This call✓ Target reached on February 26, 2026, 0 days after the note.

Firm track recordUBS: 81% of its 54 targets at least a year old were reached within 12 months (#9 of 26 firms). Accuracy ranking →

Earnings reactionOne of 7 notes after C3.ai’s Feb 25 results: 0 raised · 7 cut · 0 kept. See every call →

UBS on C3.ai

UBS price targets on C3.ai

4 calls from June 9, 2025 to October 12, 2026. The target went from $28 to $12 (−57%). The rating stayed Hold.

UBS targetAI share price
  1. October 12, 2026Kept the $12 targetHold$12
  2. June 4, 2026Target raised from $9 (+33%)Hold$12
  3. February 26, 2026 This noteTarget cut from $28 (−68%)Hold$9
  4. June 9, 2025Earliest call shownHold$28
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.